Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BioHarvest Sciences ( (BHST) ) has provided an update.
BioHarvest Sciences Inc. has secured a new contract to develop a plant-based fragrance compound using its Botanical Synthesis technology, targeting the lucrative fragrance and scents market. This agreement highlights the company’s strategic expansion into new verticals, showcasing its platform’s versatility and potential impact on conserving threatened plant species, while reinforcing its position as a transformative force in the production of valuable plant-based compounds.
The most recent analyst rating on (BHST) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology platform to grow plant-based compounds without cultivating the actual plant. The company operates in two major business verticals: as a contract development and manufacturing organization (CDMO) for novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, including dietary supplements.
Average Trading Volume: 23,684
Technical Sentiment Signal: Buy
Current Market Cap: $99.06M
See more data about BHST stock on TipRanks’ Stock Analysis page.